PTPRT

Chr 20

protein tyrosine phosphatase receptor type T

Also known as: R-PTP-T, RPTP-rho, RPTPrho

PTPRT encodes a receptor-type protein tyrosine phosphatase that regulates cellular signaling and adhesion in the central nervous system through its extracellular domain containing immunoglobulin-like repeats and intracellular catalytic domains. Mutations cause autosomal recessive neurodevelopmental disorders characterized by intellectual disability, autism spectrum disorder, and speech delays. This gene is highly constrained against loss-of-function variants in the general population, indicating that complete loss of function is likely not tolerated.

OMIMResearchSummary from RefSeq, UniProt
LOEUF 0.18
Clinical SummaryPTPRT
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.18LOEUF
pLI 1.000
Z-score 7.48
OE 0.10 (0.060.18)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
3.14Z-score
OE missense 0.70 (0.660.75)
612 obs / 872.6 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.10 (0.060.18)
00.351.4
Missense OE0.70 (0.660.75)
00.61.4
Synonymous OE1.02
01.21.6
LoF obs/exp: 8 / 80.3Missense obs/exp: 612 / 872.6Syn Z: -0.36

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PTPRT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →